Clinical study on exenatide in treatment of type 2 diabetes with hypertension
Neng-hua TANG,Liu CHEN,Wu-quan DENG,Zi-wen LIANG,Bing CHEN,Qi-nan WU
DOI: https://doi.org/10.7501/j.issn.1674-5515.2016.03.010
2016-01-01
Abstract:Objective To observe the clinical effect of Exenatide Injection in treatment of type 2 diabetes with hypertension. Methods Patients (97 cases) with type 2 diabetes with hypertension in The Hospital of Chongqing Shapingba District People’s Hospital from January 2008 to January 2015 were randomly divided into control (51 cases) and treatment (46 cases) groups. The patients in the control group were given the conventional treatment. The patients in the treatment group were scadministered with Exenatide Injection, and initial dose was 5μg/time, twice daily for four weeks. Then dose was adjusted to 10μg/time, twice daily. The patients in two groups were treated for 24 weeks. After treatment, the clinical efficacies of blood glucose and blood pressure control were evaluated. Blood glucose, blood lipid, body mass index (BMI), glycosylated hemoglobin (HbA1c), blood pressure, high sensitive C reactive protein (Hs-CRP), adiponectin and tumor necrosis factor-α (TNF-α) were compared between two groups. Results After treatment, the clinical efficacies of blood glucose control in the control and treatment groups were 58.82% and 80.43%, respectively, and there were differences between two groups (P < 0.05). While the clinical efficacies of blood pressure control in the control and treatment groups were 49.01% and 91.30%, respectively, and there were differences between two groups (P < 0.05). After treatment, fasting blood glucose (FPG), postprandial 2 h blood glucose (PPG), triglyceride (TG), and HbA1c in two groups were significantly decreased, and the difference was statistically significant in the same group (P < 0.05). After treatment, the observational indexes in the treatment group were significantly higher than those in the control group, with significant difference between two groups (P < 0.05). After treatment, total cholesterol (TC) and BMI in two groups were significantly increased, and the difference was statistically significant between two groups (P < 0.05). After treatment, systolic blood pressure (SBP) and diastolic blood pressure (DBP) in two groups were significantly decreased, and the difference was statistically significant in the same group (P < 0.05). After treatment, the observational indexes in the treatment group were significantly lower than those in the control group, with significant difference between two groups (P < 0.05). There were no difference of Hs-CRP, adiponectin, and TNF-α in the control group before and after treatment, but those index in the treatment group were significantly decreased after treatment (P < 0.05), and the observational indexes in the treatment group were significantly higher than those in the control group, with significant difference between two groups (P < 0.05).Conclusion Exenatide Injection has clinical curative effect in treatment of type 2 diabetes with hypertension, and can improve HbA1c, blood pressure, BMI, Hs-CRP, adiponectin and TNF-α, which has a certain clinical application value.